ABSTRACT The prevalence of bronchial hyperreactivity to inhaled methacholine and of a clinical history of symptoms of asthma was determined in a birth cohort of 9 year old New Zealand children. A history of current or previous recurrent wheezing was obtained in 220 of 815 children. Of 800 who had spirometric tests, 27 (3.4%) had resting airflow obstruction (FEV,/FVC < 75%). Methacholine challenge was undertaken without problem in 766 children, the abbreviated protocol being based on five breaths and four concentrations. A fall in FEV, of more than 20% was observed in 176 children (23% of challenges, 22% of the full cohort) after inhalation of methacholine in concentrations of up to 25 mg/ml. The prevalence of bronchial reactivity in children with symptoms was related to the frequency of wheezing episodes in the last year, and the degree of reactivity to the interval since the last episode. Sixty four children (8.0%) with no history of wheeze or recurrent dry cough were, however, also responsive to methacholine 25 mg/ml or less, while 35% of children with current or previous wheezing did not respond to any dose of methacholine. Bronchial challenge by methacholine inhalation was not sufficiently sensitive or specific to be useful as a major criterion for the diagnosis of asthma in epidemiological studies. The occurrence of airway reactivity in children without symptoms of asthma, however, raises the possibility that adult onset asthma and the development of airways obstruction in some subjects with chronic bronchitis could have origins in childhood.
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Asthma, although one of the most common diseases of childhood, is underdiagnosed and undertreated.'`3 The prevalence of childhood asthma is difficult to determine with certainty; estimates in New Zealand have ranged from 5% to 25%. ' 4 - 7 We have previously reported a high prevalence of a history of wheezing in 7 year old children.' Our results were in keeping with Australian findings that 11-12% of children have clinically important wheezing in the first 7-10 years of life, and that a further 20% may have mild or trivial wheezing not labelled as asthma.8 9 Some of the variation in reported prevalence is attributable to differing interpretations of a history of wheezing, and the demonstration of bronchial reac-tomatic asthma,'2 -17 methacholine challenge giving similar results to histamine challenge'5 and being more sensitive than exercise challenge.'6 '7 Few epidemiological studies using these techniques for the detection of asthma have been published.6 8 Lee et al8 found that one third of 7 year old British children with recurrent wheezing did not respond to histamine inhalation challenge, while one third of a control group of 100 symptomless children did react in some instances to very low concentrations of histamine.
As part of a longitudinal multidisciplinary study of a birth cohort of New Zealand children now aged 9 years, we sought to determine the prevalence of bronchial hyperreactivity to inhaled methacholine and to assess the value of this challenge in determining the prevalence of asthma in childhood. 31 March 1973 has been followed every two years from the age of 3, at which time 1037 children were located and were willing to participate; most were seen again at 5 and 7 years.1 At 9 years 815 of these children attended the Dunedin study centre; children examined elsewhere in New Zealand and those whose details were obtained by correspondence have not been included in this report. The characteristics of the children in this longitudinal study, and their comparability at birth with those of the cohort not followed up, have been reported. 19 The aim of the respiratory assessment was to determine the cumulative prevalence and characteristics of asthma between birth and age 9. A detailed questionnaire regarding past and current wheezing, coughing, and other respiratory symptoms was administered to the child's parent by a physician. Chest examination, spirometry, and methacholine inhalation bronchial challenge were performed after written informed parental consent had been obtained. All Resting or induced bronchoconstriction was reversed by inhalation of salbutamol 0.5% administered undiluted through a Hudson nebuliser at an airflow rate of 6 I/min for 1.5 minutes. Improvement in FEV1 was documented five minutes later; an increase of 10% or more was considered significant.
REPEATABILITY AND VALIDATION PROCEDURES
Within two months of the initial test a representative subsample of 79 subjects underwent a second study to assess the repeatability of the abbreviated methacholine challenge in children. To validate the abbreviated challenge procedure, a further 30 selected subjects, 22 of whom had shown reactivity with our protocol, were recalled for methacholine challenge according to the protocol of Hargreave et al,22 in which twofold concentration increments (methacholine 0.03-32.0 mg/ml) were inhaled by tidal breathing for two minutes from a closely fitting facemask attached directly to a Wright's nebuliser delivering 0.13 + 0.015 ml/min at an airflow rate of 6 I/min.
STATISTICAL ANALYSIS
The relationships between PC20FEV1 values and spirometric and clinical data were explored with x2 tests, t tests, and analyses of variance. Since differences in percentage fall in FEV1 and in PC20FEV1 in the repeatability and validation studies were proportional to the size of the measurement, logarithmic transformations were carried out before analysis. Differences were analysed with the test of reliability described by Fleiss23 and the analysis of comparison studies described by Altman and Bland.24 
Results
Of the 1037 children entering the study at age 3, 815 (431 boys, 384 girls) were seen at the study centre at the age of 9. Although these represented only half of the birth cohort of 1661 children, they appear to have been a fair reflection of the original sample. The children not entered into the study at the age of 3 did not differ significantly in their birth and perinatal characteristics from those enrolled in the study,19 and the gradual loss of 222 children over the subsequent six years has not altered significantly the socioeconomic or other epidemiologically important characteristics of the cohort.
Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children figure 1 . Reactivity to methacholine occurred more frequently at lower concentrations in those with more severe asthma. Reactivity was not, however, invariable among children with symptoms (table 1). The prevalence of reactivity to salbutamol and methacholine was directly related to the frequency ofepisodes during the year before the methacholine challenge (table 2) ; all with daily wheeze were reactive to methacholine, as were 88% of those whose episodes occurred at least monthly. But 35% of children with three or more wheezing episodes in the year before challenge and without resting airflow obstruction did not respond to methacholine 25 mg/ml. The degree of reactivity was related to the interval since the last episode of wheezing, a shorter interval being associated with a lower PC20FEV1 (p < 0.001).
Despite these relationships, 50.5% of the 220 children with a history of recurrent wheezing did not respond to the highest dose of methacholine. Of the 147 children with mild or moderate or severe asthma at some time during their nine years, 16% had resting airflow obstruction, 5% declined methacholine challenge, 44% had a PC20FEV1 less than 25 mg/ml, and the remaining 35% failed to achieve a 20% fall in FEV1 after inhaling methacholine 25 mg/ml. This was not simply related to the frequency or severity of episodes, since in a selected group of 38 children with three to 12 episodes of wheezing in the last year 11% had resting airflow obstruction, 42% responded to methacholine, and 47% did not achieve a 20% fall in FEV1 after methacholine 25 mg/ml. In this group, those with reactivity and those without did not differ in mean age of onset of wheezing or in the interval since their last episode.
On the other hand, not all children with bronchial reactivity had had respiratory symptoms. Twenty six of the 27 children with resting airflow obstruction had a previous or current history of wheeze or recurrent cough, but only 64% of the 176 children with a methacholine PC20FEV1 value less than 25 mg/ml had had symptoms. Bronchial reactivity without any previous symptoms was found in 65 children. One had resting reversible airflow obstruction and 64 (41 boys and 23 girls; 13.3% of all symptomless children) showed a response to the doses of methacholine given; of these, 40 had PC20FEV1 < 10 mg/ml, 18 < 5.0 mg/ml, and six < 2.5 mg/ml.
REPEATABILITY AND VALIDATION STUDIES
The abbreviated challenge was repeated in 79 children, 49 of whom did not respond to methacholine 25 mg/ml in either test while 14 responded in both tests. Thus 80% of children retained the same classification of "reactive" or "non-reactive" on repeat testing. Eight with a greater than 20% fall in FEV1 in the first test had a fall of under 20% on repeat Laitinen and Kava28 found no increase in histamine induced change in specific airway conductance in healthy subjects given a nasal inoculation of influenza A virus, whereas asthmatic subjects given the same inoculation showed increased reactivity.
Children with a history of wheezing showed significant relationships between the degree of airway reactivity and both the frequency of symptoms over the previous year and the interval between the most recent episode and the methacholine challenge. A relationship between bronchial reactivity and the frequency and severity of clinical asthma has been found repeatedly20 [29] [30] [31] [32] but bronchial reactivity without symptoms is less well documented. While some children reported as showing asymptomatic bronchial reactivity may have had symptoms not recalled by the mother, the interval from the episode to the methacholine challenge would be most likely to be long and the severity of the episode minimal for it not to be recalled on direct and searching questioning. The present study confirms the findings of Lee et al8-namely, that bronchial hyperreactivity may be present in children in the absence of respiratory symptoms.
Simonsson33 tabled seven reports of bronchial reactivity to methacholine in "normal" adult subjects; the maximum number of subjects in any one study was 62. 13 The concentrations and doses of methacholine administered and the measurement of lung function varied but these studies suggest a degree of bronchial hyperreactivity in the normal adult population similar to that in children. Heightened bronchial responsiveness in adults may have its origins in childhood. Whether increased responsiveness continues to be asymptomatic, or perhaps predisposes to the later development of asthma or airflow obstruction in patients with chronic bronchitis,34 is conjectural; and the question could be answered only by long term follow up of children such as these.
In summary, we have shown that 25% of 9 year old children had evidence of airway reactivity, revealed either by resting airflow obstruction relieved with salbutamol or by responsiveness to inhalation of methacholine. While the presence of airway reactivity was associated broadly with symptoms of asthma, a substantial number of children (8% of 800 tested) had mild or moderate increases in airway reactivity but denied any respiratory symptoms. On the other hand, 35% of children with recent or past histories of more than trivial wheezing did not show increased responsiveness to methacholine. We conclude that heightened bronchial responsiveness is a common phenomenon in childhood but that bronchial challenge is not sufficiently sensitive or specific to make its use in epidemiological studies of asthma mandatory. Rather, for both epidemiologist and clinician, a detailed history indicating recurrent episodes of wheezing should lead to a diagnosis of asthma.
